Literature DB >> 18045627

Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat.

Shane A Perrine1, Imran S Sheikh, Chinwe A Nwaneshiudu, Joseph A Schroeder, Ellen M Unterwald.   

Abstract

Chronic administration of cocaine has been shown to attenuate the functional capacity of delta opioid receptors to inhibit adenylyl cyclase activity. Abuse and withdrawal from cocaine in humans is associated with increases in anxiety and depression. Since recent research supports the role of delta opioid receptors in anxiety- and depression-like behaviors in rodents, we hypothesized that functional desensitization of delta opioid receptors contributes to anxiety- and depression-like behavioral phenotypes following short-term withdrawal from chronic administration of cocaine. To test this hypothesis, delta opioid receptor signaling and behaviors were evaluated 24h after 14days of binge-pattern cocaine administration (15mg/kg three times daily at 1h intervals) in male Sprague-Dawley rats. Results showed that the inhibition of adenylyl cyclase by delta opioid receptor agonists was attenuated in the frontal cortex, nucleus accumbens and caudate putamen 24h after cessation of cocaine administration. One day withdrawal from chronic administration of cocaine resulted in increased anxiety- and depression-like behaviors as measured by the elevated plus maze and the forced swim test respectively, and no change in locomotor activity. The anxiety- and depression-like behaviors were dose-dependently reduced by acute administration of the selective delta opioid receptor agonist, SNC80. These results demonstrate that early withdrawal from cocaine resulted in increased anxiety and depression, which accompanies the desensitization of delta opioid receptor function. Furthermore, cocaine-induced anxiety- and depression-like behaviors were reversible by the delta opioid receptor agonist SNC80.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045627      PMCID: PMC2254761          DOI: 10.1016/j.neuropharm.2007.10.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  62 in total

1.  Behavioral sensitization to binge-pattern cocaine administration is not associated with changes in protein levels of four major G-proteins.

Authors:  Shane A Perrine; Joseph A Schroeder; Ellen M Unterwald
Journal:  Brain Res Mol Brain Res       Date:  2005-02-18

2.  Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.

Authors:  M Mas Nieto; S L E Guen; B L Kieffer; B P Roques; F Noble
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization.

Authors:  A L Svingos; C L Clarke; V M Pickel
Journal:  Synapse       Date:  1999-10       Impact factor: 2.562

Review 4.  The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.

Authors:  I Lucki
Journal:  Behav Pharmacol       Date:  1997-11       Impact factor: 2.293

5.  Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin.

Authors:  A L Svingos; C L Clarke; V M Pickel
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

Review 6.  Cocaine potentiates defensive behaviors related to fear and anxiety.

Authors:  D C Blanchard; R J Blanchard
Journal:  Neurosci Biobehav Rev       Date:  1999-11       Impact factor: 8.989

7.  The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task.

Authors:  B J Hoplight; E S Vincow; J F Neumaier
Journal:  Physiol Behav       Date:  2005-04-13

8.  Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.

Authors:  A M Basso; M Spina; J Rivier; W Vale; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1999-07       Impact factor: 4.530

9.  Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.

Authors:  Akiyoshi Saitoh; Yuji Yoshikawa; Kenji Onodera; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

10.  Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.

Authors:  M H Baumann; R B Rothman
Journal:  Biol Psychiatry       Date:  1998-10-01       Impact factor: 13.382

View more
  56 in total

1.  Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Eduardo R Butelman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2012-04-04       Impact factor: 5.250

2.  Effects of delta opioid receptors activation on a response inhibition task in rats.

Authors:  Katia Befort; Megan K Mahoney; Carmen Chow; Scott J Hayton; Brigitte L Kieffer; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2010-12-23       Impact factor: 4.530

3.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 4.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

5.  Sex differences in morphine-induced behavioral sensitization and social behaviors in ICR mice.

Authors:  Bo Zhan; Hong-Yuan Ma; Jian-Li Wang; Chao-Bao Liu
Journal:  Dongwuxue Yanjiu       Date:  2015-03-18

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

7.  Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.

Authors:  Shawn M Vuong; Harvey A Oliver; Jamie L Scholl; Kathryn M Oliver; Gina L Forster
Journal:  Behav Brain Res       Date:  2009-12-01       Impact factor: 3.332

8.  Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.

Authors:  Lisa M Ambrose-Lanci; R C Sterling; Elisabeth J Van Bockstaele
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

9.  Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice.

Authors:  Jessica N Cleck; Laurel E Ecke; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2008-08-03       Impact factor: 4.530

10.  Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.

Authors:  Diana Simmons; David W Self
Journal:  Neuropsychopharmacology       Date:  2009-03-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.